China's Vcanbio Opens Boston Offices to Hunt for Cell and Immuno-Therapy Products
September 13, 2016 at 04:31 AM EDT
China's Vcanbio Cell & Gene Engineering Corporation, a Tianjin stem cell and cord banking company, has opened two subsidiary companies in the Boston area. Vcanbio USA will be the company's North America investment arm, specializing in novel cell therapy and immunotherapy products. Vcanbio CTB will offer CRO-type translation services for novel therapies, which will operate through partnerships and co-development. More details.... Stock Symbol: (SHA: 600645) Share this with colleagues: // //